Skip to content
10-Q

Quarterly Report

MANHATTAN SCIENTIFICS, INC.

0001477932-24-002983

← back to feed
Filed
May 15, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 13, 2024 559.28M sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$42K
Stockholders Equity Q1 2024 · Mar 31, 2024 −$3.24M
Stockholders Equity Q1 2024 · Dec 31, 2023 −$2.86M
Current Liabilities Q1 2024 · Mar 31, 2024 $2.28M
Current Liabilities Q1 2024 · Dec 31, 2023 $2.12M
Total Liabilities Q1 2024 · Mar 31, 2024 $2.28M
Total Liabilities Q1 2024 · Dec 31, 2023 $2.12M
Current Assets Q1 2024 · Mar 31, 2024 $60K
Current Assets Q1 2024 · Dec 31, 2023 $69K
Total Assets Q1 2024 · Mar 31, 2024 $91K
Total Assets Q1 2024 · Dec 31, 2023 $316K
Eps Diluted Q1 2024 · Mar 31, 2024 $0.00
Eps Basic Q1 2024 · Mar 31, 2024 $0.00
Sga Expense Q1 2024 · Mar 31, 2024 $189K
Rd Expense Q1 2024 · Mar 31, 2024 $3K
Net Income Q1 2024 · Mar 31, 2024 −$382K
Operating Income Q1 2024 · Mar 31, 2024 −$192K
Revenue Q1 2024 · Mar 31, 2024 $0